Compare Rubrik Inc. Class A Common Stock (RBRK) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rubrik Inc. Class A Common Stock vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Rubrik Inc. Class A Common Stock trades at $123.49 (market cap $25.06B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.63 (market cap $2.27B). The key difference: Rubrik Inc. Class A Common Stock is far larger — about 11× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Rubrik Inc. Class A Common Stock is trading nearer its 52-week high, SELLAS Life Sciences Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals.
| RBRK | SLS | |
|---|---|---|
Market Cap | $25.06B | $2.27B |
Volume | 2,394,852 | 4,179,659 |
Sector | Technology | Health |
52-Week High | $125.80 | $15.46 |
52-Week Low | $43.81 | $1.39 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $24.46B | $2.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Rubrik Inc. Class A Common Stock
Rubrik provides data security and cyber recovery software for enterprises. Its platform protects data across on-premises, cloud, SaaS, and unstructured-data environments.
Read more on RBRK →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
